AGC
EXAS

Angelo Gordon & Co’s Exact Sciences EXAS Stock Holding History

Angelo Gordon & Co’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$14.2M Buy
+140,000
New +$11.2M 1.34% 24

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Angelo Gordon & Co's EXAS Position: Q4 2025 in Review

Angelo Gordon & Co opened a new position in Exact Sciences (EXAS) in Q4 2025: 140,000 shares worth $14.2M. The stake represents 1.34% of the portfolio and ranks #24 among its holdings.

711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • Angelo Gordon & Co held 140,000 shares of Exact Sciences worth $14.2M as of Q4 2025.
  • Exact Sciences was a new Angelo Gordon & Co position in Q4 2025.
  • Exact Sciences made up 1.34% of Angelo Gordon & Co's portfolio in Q4 2025, its #24 holding.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Angelo Gordon & Co's 13F filing for Q4 2025, filed 17 Feb 2026.